Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
“This recommendation was based on observational studies, not on a prospective randomized trial. But some electrophysiologists (EPs) continue to believe that it’s sufficient to create incomplete linear lesions where conduction sites still exist between the pulmonary veins and left atrium,” explained Professor Karl Kuck, from Asklepios Klinik St George, Hamburg ,Germany, presenter of the GAP-AF study.
“The study shows us for the first time that complete isolation of the pulmonary veins is more effective than incomplete isolation. It suggests that the level of evidence for complete ablation should be upgraded from class Ic to class Ia, where it is supported by a multicentre randomized trial,” said Prof. Kuck.
“Our study shows that, if proper selection criteria are applied, ablation can achieve good results for patients with persistent AF,” said Mont. “It’s likely to have an impact on guidelines and may contribute to an upgrade of ablation in persistent AF to category 1B.” Results would not apply to patients with very dilated atrium and long standing persistent AF.
Scientific Programme Online
© 2017 European Society of Cardiology. All rights reserved